To date, there have been few reports of dupilumab-associated autoimmune endocrine disorders, such as painless thyroiditis accompanied by hypothyroidism [4], type 1 diabetes [5], and hyperthyroidism with negative TSHR-Ab [6]. Here, TSHR is linked to hyperthyroidism.